Adverse events (reported occurrence of: mild reduction in the visual acuity of the sound eye not requiring treatment; light sensitivity; skin, lid, or conjunctival irritation) Assessed at different time points (17 weeks or 2 years). · Participants of any age with either unilateral strabismic, anisometropic, or mixed (strabismic‐refractive) amblyopia; deprivation…
1 finding from 1 review
Depressive symptoms · various
1 finding from 1 review
Anxiety · various
1 finding from 1 review
General functioning ‐ not measured · various
1 finding from 1 review
Dropout · various
Any early psychological intervention may leads to higher dropouts from treatment compared with active control condition (low certainty).
1 finding from 1 review
Severity of PTSD symptoms · various
1 finding from 1 review
Weight or BMI (at end of 12 months from the start of treatment) · participants with anorexia nervosa
Summary of findings: Specialist inpatient care for weight restoration showed no clear difference in weight or BMI (at end of 12 months from the start of treatment) compared with active outpatient or combination brief hospital/outpatient care (low certainty).
1 finding from 1 review
Secondary outcome: acceptability of treatment · participants with anorexia nervosa
It is very uncertain whether summary of findings: Specialist inpatient care for weight restoration changes acceptability: number of participants who completed treatment (at… compared with active outpatient or combination brief hospital/outpatient care (very low certainty).
1 finding from 1 review
Adherence · adults with obstructive sleep apnoea
1 finding from 1 review
Adverse effects Measured as number of participants who discontinued device at end of 2 months · adults with obstructive sleep apnoea
1 finding from 1 review
Quality of life Assessed using SF‐36 or FOSQ · adults with obstructive sleep apnoea
1 finding from 1 review
Sleep quality Assessed by average duration of slow‐wave and REM sleep periods · adults with obstructive sleep apnoea
1 finding from 1 review
Cognitive dysfunction · adults with obstructive sleep apnoea
1 finding from 1 review
Daytime sleepiness (ESS): change from baseline. · adults with obstructive sleep apnoea
1 finding from 1 review
AHI · adults with obstructive sleep apnoea
1 finding from 1 review
Participant‐reported pain relief of 50% or greater · adults with sickle cell disease in a vaso‐occlusive crisis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participant‐reported pain relief of 30% or greater · adults with sickle cell disease in a vaso‐occlusive crisis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
PGIC very much improved · adults with sickle cell disease in a vaso‐occlusive crisis
1 finding from 1 review
Patient Global Impression of Change much or very much improved · adults with sickle cell disease in a vaso‐occlusive crisis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Any adverse event ( · adults with sickle cell disease in a vaso‐occlusive crisis
1 finding from 1 review